BioScience Health Innovations BHIC
OTC BHIC
$4.01 -0.99 (-19.80%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioScience Health Innovations (BHIC) Total Non-Current Liabilities (2023 - 2024)

BioScience Health Innovations (BHIC) posted quarterly Total Non-Current Liabilities of $10947.0 for Q3 2024, up 36.29% year-over-year from $8032.0 in Q4 2023, and up 21.48% quarter-over-quarter from $9011.0 in Q2 2024.

BioScience Health Innovations (BHIC) Total Non-Current Liabilities (2023 - 2024) Analysis & Trends

BioScience Health Innovations (BHIC) has reported Total Non-Current Liabilities for 2 consecutive years, with $10947.0 the latest figure, recorded in Q3 2024.

  • In Q3 2024, Total Non-Current Liabilities rose 36.29% year-over-year to $10947.0; the TTM figure through Sep 2024 stood at $10947.0 (up 36.29% YoY), while the FY2023 annual figure was $13074.0, up 280.61% from the prior year.
  • Total Non-Current Liabilities advanced to $10947.0 in Q3 2024 per BHIC's latest filing, from $9011.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $15235.0 in Q1 2023 and bottomed at $901.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 High Tide 215.72 Mn 182.44 Mn 35.30 Mn 113.84 Mn
2 BioScience Health Innovations 58.76 Mn 58.05 Mn 659,483.00 -
3 Petmed Express 38.29 Mn 25.19 Mn 11.33 Mn -
4 Scienture Holdings 17.81 Mn 17.81 Mn 335,779.00 -
5 Polomar Health Services 8.48 Mn 8.31 Mn 935,916.00 -
6 Ridgetech 58,214.34 -17.85 Mn - 356,353.00

Historic Data

Download Data
DateValue
Sep 30, 2024 10,947.00
Jun 30, 2024 9,011.00
Mar 31, 2024 6,128.00
Dec 31, 2023 13,074.00
Sep 30, 2023 8,032.00
Jun 30, 2023 901.00
Mar 31, 2023 15,235.00